Geranylgeraniol — GGOH (Acyclic Diterpene · Statin Myopathy Prevention · Bone Health)
| Compound | Geranylgeraniol (GGOH) |
| Chemical class | Terpenoid — Acyclic Diterpene Alcohol (C20) |
| CAS | 24034-73-9 |
| Primary source | Bixa orellana (annatto), Coleus forskohlii (forskolin co-constituent), many plant sources |
| Key applications | Statin myopathy prevention, anti-osteoporosis, antiviral, vitamin E/K precursor |
| Claim strength | Moderate |
| Typical form | Annatto extract (GGOH-standardised); geranylgeraniol isolate; statin adjunct supplement |
| Buy from Herbuno |
Name origin: From geranyl (C10) + geranyl (added C10) = geranylgeranyl (C20) + -ol (alcohol). Geranylgeraniol (GGOH) is the C20 isoprenoid alcohol produced from geranylgeranyl pyrophosphate (GGPP) in the mevalonate pathway — the same pathway inhibited by statin drugs. It is a biosynthetic precursor to diterpenes, carotenoids, gibberellins, tocopherols (vitamin E), and chlorophylls in plants. Traditional use: Annatto (Bixa orellana, Roucou, Achiote) has been used by indigenous South American peoples for body paint, food colouring, and traditional medicine for centuries. Its seeds provide the orange-red bixin pigment (a carotenoid) used in butter, cheese, and cosmetics. GGOH co-occurs in annatto seeds alongside bixin. Research trajectory: GGOH has attracted significant interest since research demonstrated that statin drugs deplete GGOH (by blocking the mevalonate pathway that produces GGPP from which GGOH is derived). GGOH depletion is implicated in statin-associated myopathy (muscle weakness and pain), the most clinically significant statin side effect. GGOH supplementation has been investigated as a mitigation strategy for statin myopathy. Commercial source: Annatto Extract Powder (Bixin 5% and 3%) from Herbuno provides GGOH alongside bixin/norbixin carotenoids. See sourcing options below.
Evidence for Geranylgeraniol Applications
Statin myopathy prevention: GGOH is depleted by statins through mevalonate pathway inhibition — the same pathway that produces CoQ10, which is more widely known as a statin-depleted nutrient. Supplementing GGOH restores geranylgeranylation of muscle proteins (Rab GTPases, RhoA) that are required for normal muscle cell function. Animal studies confirm GGOH supplementation prevents statin-induced myopathy. A human pilot study (Flint et al.) showed GGOH supplementation reduced statin-associated muscle weakness markers. Claim strength: Moderate (mechanism compelling; limited human RCT data).
Anti-osteoporosis: GGOH promotes osteoblast differentiation and bone mineralisation. It inhibits osteoclast activity (reduces bone resorption). Statins are known to have incidental bone-protective effects; GGOH depletion may partially counteract this. Animal osteoporosis models confirm GGOH’s bone-protective activity. Claim strength: Moderate (animal data).
Antiviral: GGOH inhibits replication of multiple viruses by interfering with viral protein geranylgeranylation (post-translational modification required for viral assembly). Active against CMV, EBV, and HCV in cell models. Claim strength: Moderate (preclinical).
Metabolic precursor roles: GGOH is the metabolic precursor to tocotrienols (vitamin E isoforms), chlorophylls, phytol, diterpenes, and geranylgeranylated proteins essential for cellular signalling. Its supplementation in statin users addresses a broader isoprenoid depletion beyond CoQ10. Claim strength: Moderate (metabolic role well-established).
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Statin myopathy prevention: human pilot data used 150–300 mg/day GGOH. This is achievable from concentrated GGOH supplements derived from annatto seed extraction. Annatto bixin extract from Herbuno (Bixin 3% and 5%) co-delivers GGOH as a minor isoprenoid constituent alongside the primary bixin/norbixin carotenoid — for GGOH-specific positioning, request quantification of the GGOH fraction separately from bixin. Purpose-built GGOH supplements (from annatto or other plant sources) standardised specifically to geranylgeraniol content are emerging as a statin adjunct category. For bone health applications, 150 mg/day GGOH from annatto is the dose studied in animal osteoporosis models.
Frequently Asked Questions — Geranylgeraniol
Is geranylgeraniol the same as CoQ10 as a statin supplement?
They address different aspects of statin-induced mevalonate pathway depletion. CoQ10 depletion from statin use is the most widely studied and supplemented concern — CoQ10 is needed for mitochondrial energy production in muscle. GGOH depletion addresses a distinct problem: geranylgeranylation of muscle proteins (Rab GTPases, RhoA) required for muscle cell cytoskeletal dynamics, vesicular trafficking, and protein localisation. Both depletions may contribute to statin myopathy through different mechanisms. For comprehensive statin adjunct formulation, both CoQ10 and GGOH address complementary pathways.
Why is GGOH depleted by statins?
Statins inhibit HMG-CoA reductase — the rate-limiting enzyme of the mevalonate pathway. This reduces production of mevalonate, from which all downstream isoprenoids are synthesised: CoQ10, dolichols, geranylgeranyl pyrophosphate (GGPP), farnesyl pyrophosphate (FPP), and squalene (cholesterol precursor). GGOH is produced from GGPP (dephosphorylation), so statin-induced GGPP depletion directly reduces GGOH availability for protein geranylgeranylation and other functions. This is why statin myopathy is a class-wide effect — all statins inhibit this pathway regardless of their specific pharmacokinetics.
Is annatto a good source of GGOH or primarily a bixin source?
Annatto seeds contain both bixin/norbixin (the orange-red apocarotenoid pigments, typically 3–5%) and geranylgeraniol (the isoprenoid alcohol). Commercial annatto extraction is primarily optimised for bixin as the primary commercial product. GGOH is a co-constituent that has received less attention in commercial standardisation. For GGOH-focused applications, annatto-derived GGOH preparations (standardised to GGOH content rather than bixin) are emerging as a specific supplement category; they are distinct from standard annatto bixin extract.
Can GGOH be used as a vitamin K/E precursor in supplement formulations?
In plants, GGOH (via GGPP) is the biosynthetic precursor to the phytyl side chain of vitamin K (phylloquinone) and to tocotrienols (vitamin E). In human metabolism, GGOH serves as the substrate for geranylgeranylation of proteins and is converted to geranylgeranyl-PP in cells. It does not directly serve as a vitamin K or E precursor in human metabolism in the same way as in plants. GGOH supplementation replenishes the isoprenoid pathway depleted by statins — this is its primary human supplement rationale, not vitamin K/E provision.
Related compounds: Phytol, Farnesol, Cycloastragenol, Ursolic Acid
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery